Telesis Bio Q4 EPS $(0.61) Misses $(0.22) Estimate, Sales $6.98M Miss $7.00M Estimate
Telesis Bio Q4 EPS $(0.61) Misses $(0.22) Estimate, Sales $6.98M Miss $7.00M Estimate
Telesis Bio第四季度每股收益美元（0.61美元）未達到預期（0.22美元），銷售額爲698萬美元，未達到700萬美元的預期
Telesis Bio (NASDAQ:TBIO) reported quarterly losses of $(0.61) per share which missed the analyst consensus estimate of $(0.22) by 177.27 percent. This is a 117.86 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $6.98 million which missed the analyst consensus estimate of $7.00 million by 0.33 percent. This is a 26.32 percent decrease over sales of $9.47 million the same period last year.
Telesis Bio（納斯達克股票代碼：TBIO）公佈的季度虧損爲每股0.61美元，比分析師普遍預期的0.22美元（0.22美元）低177.27％。與去年同期每股虧損0.28美元（0.28）相比，下降了117.86％。該公司公佈的季度銷售額爲698萬美元，比分析師普遍預期的700萬美元低0.33％。這比去年同期的947萬美元銷售額下降了26.32％。